Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
about
Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington’s DiseaseGenomewide association study for onset age in Parkinson disease.Genetic Modifiers of Age at Onset in Carriers of the G206A Mutation in PSEN1 With Familial Alzheimer Disease Among Caribbean Hispanics.Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onsetTAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region.Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease.Genetic background modulates behavioral impairments in R6/2 mice and suggests a role for dominant genetic modifiers in Huntington’s disease pathogenesis.Genetic analysis of the GRIK2 modifier effect in Huntington's disease.Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease.Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteinsChromosome substitution strain assessment of a Huntington's disease modifier locusRNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression.Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset.Modifier genes as therapeutics: the nuclear hormone receptor Rev Erb alpha (Nr1d1) rescues Nr2e3 associated retinal diseaseA brief history of triplet repeat diseases.Molecular mechanisms and potential therapeutical targets in Huntington's disease.The clinical and genetic features of Huntington disease.Genetic modifiers of neurological diseaseThe biological function of the Huntingtin protein and its relevance to Huntington's Disease pathologyGenetic modifiers of Huntington's disease.Inducible mutant huntingtin expression in HN10 cells reproduces Huntington's disease-like neuronal dysfunction.Modulation at age of onset in tunisian huntington disease patients: implication of new modifier genesResponse to Falush: a role for cis-element polymorphisms in HD.A retrospective study of the impact of lifestyle on age at onset of Huntington disease.The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.Effects of an intensive rehabilitation programme on patients with Huntington's disease: a pilot study.Molecular characterization of genes modifying the age at onset in Huntington's Disease in Uruguayan patients.
P2860
Q27311065-84524583-1AB9-4625-98EF-C01F45A288DEQ29417034-0F785CD1-C579-45D2-AACC-59C677C4FAC2Q30009136-3B2B2A68-FEFC-4284-B3BA-4E47FAF76E8CQ30416270-CAF9473A-80F1-4975-A2BE-775D06FC588FQ30417570-F3136057-A04C-4FE3-85B9-6256943836EDQ30425027-55C707E2-3ADC-42C1-9AF4-FA4E5BB24F49Q30425270-62F5920B-CDB9-4BA1-B9E8-7988A287BC85Q30467288-588EA5CB-0724-4C11-9E57-96D8A4B18079Q33256755-F67F5799-AA34-4A70-B13C-FDF71568816CQ34498391-2914C9B1-1FE2-42CA-ABDA-0F71CC962C44Q35080634-AC8FA65C-073D-48D5-A298-773D293453F4Q35214662-673FD2EF-DF70-4EAA-996C-183460A60BA4Q35860947-1027B392-7A11-4495-8BBA-2780D8BBE1A2Q37004508-AE6B83E3-77C1-45D2-9424-D5D11888EB78Q37272365-17580A80-5A4E-426E-B4E9-470A62533703Q37539468-8173892E-D90C-4025-8011-4FBD83AD733EQ37553564-899986F4-50ED-4D83-9C62-0F93E46995E6Q37776087-BD6F4DD5-43C3-4185-B3A4-8748DCB44403Q37798079-06ABFF47-FC84-4B8B-88FA-547160653F7FQ37830879-D8E68595-7112-4ADE-9451-63ACBFCAE439Q37969749-D0E613A4-17F5-4B37-8518-3AEC7CD175B8Q38243002-2BE5C38C-2938-47C7-9374-0532E2365DE4Q39885837-718BE867-AAD7-458C-BE64-94405C0F9C4FQ42151377-F6D8085C-A5B7-4D6F-AA9A-BAA3081A963EQ42958171-A8148F0E-D10B-4C3D-A093-B38B4908312AQ45298844-23CEF5DD-AE3B-4395-9B92-04ECFE4CD101Q45301737-76001A57-0971-4265-8809-6676FE4C2DEEQ45305946-465548FD-64A7-4DD9-933B-7F570E8C805DQ45306073-783EEF50-6A1F-4657-9939-79E21A8E5D85
P2860
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
@ast
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
@en
type
label
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
@ast
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
@en
prefLabel
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
@ast
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
@en
P2093
P2860
P50
P1433
P1476
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16
@en
P2093
Adam Rosenblatt
Alexandra Durr
Andrea Zanko
Beth Knowlton
Catherine Dode
David Mayo Cabrero
Elisabeth W Almqvist
Elizabeth McCusker
Estrella Gómez-Tortosa
Jayalakshmi Mysore
P2860
P2888
P304
P356
10.1007/S10048-004-0175-2
P50
P577
2004-03-17T00:00:00Z